NOVORAPID

国: イスラエル

言語: 英語

ソース: Ministry of Health

有効成分:

INSULIN ASPART

から入手可能:

NOVO NORDISK LTD., ISRAEL

ATCコード:

A10AB05

医薬品形態:

SOLUTION FOR INJECTION

構図:

INSULIN ASPART 100 U/ML

投与経路:

I.V, S.C

処方タイプ:

Required

製:

NOVO NORDISK A/S, DENMARK

治療領域:

INSULIN ASPART

適応症:

Treatment of patients with diabetes mellitus in adults, adolescents and children aged 2 years and above.

承認日:

2020-06-30

情報リーフレット

NovoRapid Vial IL PIL FEB-2021-NOTIFICATION
Page 1 of 11
Patient leaflet in accordance with the Pharmacists' Regulations
(Preparations) - 1986
The dispensing of this medicine requires a doctor’s prescription
NovoRapid
®
Vial 100 units/ml
Solution for injection in a vial
Active substance: Insulin aspart 100 units/ml
Inactive substances and allergens in this medicine: see section 2
"Important information about
some of this medicine's ingredients
" and section 6 "Additional information
".
Read all of this leaflet carefully before you start using this
medicine. This leaflet contains
concise information about this medicine. If you have any further
questions consult your doctor or
pharmacist.

This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if it seems to you that their medical condition is similar to
yours.

This medicine is intended for adults, adolescents, and children over
two years old.
1. What is this medicine intended for?
NovoRapid
®
is used to reduce the high blood sugar level in adults, adolescents,
and children aged 2
years and above with diabetes.
Therapeutic group: Medicines for the treatment of diabetes.
Fast-acting insulins and insulin
analogs for injection.
NovoRapid
®
is a modern insulin (insulin analog) with a rapid-acting effect.
Modern insulin products
are improved versions of human insulin.
Diabetes is a disease where your body does not produce enough insulin
to control the level of your
blood sugar. Treatment with NovoRapid
®
helps to prevent complications from your diabetes.
NovoRapid
®
will start to lower your blood sugar 10–20 minutes after you inject
it, a maximum effect
occurs between 1 and 3 hours after the injection and the effect lasts
for 3–5 hours. Due to this short
action NovoRapid
®
should normally be taken in combination with intermediate-acting or
long-acting
insulin preparations. NovoRapid
®
can also be used for continuous infusion in a pump system.
NovoRapid Vial IL PIL FEB-2021-NOTIFICATION
Page 2 of 11
2. Befo